等待開盤 03-26 09:30:00 美东时间
+0.110
+0.10%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Dollar Tree业绩会实录,以下是2025年第四季度财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 第四季度净销售额达到55亿美元,同比增长9%,其中可比店铺销售额增长5%,净新开店贡献4%。全年营收表现强劲,连续20年实现正可比店铺销售增长。 **利润率表现:** 毛利率大幅改善,同比扩张150个基点,主要受益于商品利润率提升、运费成本降低、向高利润率非必需品类别的有利组合转变以及占用成本杠杆效应。调整后营业利润率提升20个基点至12.8%。 **盈利能力:** 调整后营业收入同比增长11%。调整后稀释每股收益同比增长21%
03-25 12:10
Price shock pushes shoppers toward Walmart and dollar stores. Who are the retail winners?
03-24 22:01
UPDATE 2-Canada's Dollarama forecasts annual sales largely below estimates Adds background and detail throughout March 24 (Reuters) - Dollarama DOL.TO forecast 2027 sales largely below Wall Street estimates on Tuesday , aligning with its American peers in preparing for muted consumer spending amid r
03-24 19:14
BUZZ-US consumer, retail stocks up amid broader market rise ** Shares of U.S. retailers rise as risk appetite returned to markets after U.S. President Donald Trump said he had ordered the military to postpone strikes against Iranian power plants and energy infrastructure following "productive conver
03-23 22:43
从航空公司到快餐连锁店,多家公司正在股东报告中增加有关伊朗战事的披露内容,就其担心可能发生的长期干扰做出预警。 伊朗战事已进入第三周,且尚无结束迹象,在...
03-20 18:12
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson March 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Eli Lilly and Johnson & Johnson on Tuesday. HIGHLIGHTS * Biogen BIIB.O : HSBC raises target pri
03-17 15:31
Dollar Tree stock rises after Q4 earnings beat estimates and sales jump 9%, as the retailer issues a steady growth outlook for 2026.
03-16 23:05
BUZZ-Dollar Tree rises after quarterly profit beats estimates Updates ** Shares of discount retailer Dollar Tree DLTR.O up as much as ~6% at $113.61 ** Stock set for its best day in more than three months, if gains hold ** Co beats Q4 profit estimates, sees a favorable tariff impact in the near term
03-16 22:45